Tower Research Capital LLC (TRC) - EDGEWISE THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of EDGEWISE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$34,701
+266.1%
6,056
+395.2%
0.00%
Q2 2023$9,478
+8595.4%
1,223
-92.5%
0.00%
-100.0%
Q1 2023$109
+84.7%
16,400
+148.3%
0.00%
+50.0%
Q4 2022$59
-99.8%
6,604
+74.9%
0.00%
+100.0%
Q3 2022$37,000
+270.0%
3,775
+209.4%
0.00%
Q2 2022$10,000
-52.4%
1,220
-43.0%
0.00%
Q1 2022$21,000
+5.0%
2,142
+67.2%
0.00%
Q4 2021$20,000
+150.0%
1,281
+172.0%
0.00%
Q3 2021$8,000
+33.3%
471
+60.2%
0.00%
Q2 2021$6,0002940.00%
Other shareholders
EDGEWISE THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,553,661$50,494,00011.75%
Novo Holdings A/S 5,587,207$181,584,0007.50%
Orbimed Advisors 13,944,680$453,202,0004.24%
Logos Global Management LP 1,056,812$34,346,0003.35%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,933,137$127,827,0002.69%
EcoR1 Capital, LLC 1,224,175$39,786,0001.76%
Cormorant Asset Management, LP 2,340,914$74,307,0001.66%
Octagon Capital Advisors LP 125,000$4,063,0001.53%
RA Capital Management 2,613,623$84,943,0001.28%
Soleus Capital Management, L.P. 100,000$3,250,0000.59%
View complete list of EDGEWISE THERAPEUTICS INC shareholders